Dawn Christine Maroney Sells 30,000 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the business’s stock in a transaction on Monday, March 16th. The stock was sold at an average price of $17.48, for a total transaction of $524,400.00. Following the transaction, the president owned 1,095,562 shares of the company’s stock, valued at approximately $19,150,423.76. The trade was a 2.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, March 12th, Dawn Christine Maroney sold 29,113 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.45, for a total value of $508,021.85.
• On Tuesday, February 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.63, for a total value of $618,900.00.
• On Thursday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $22.48, for a total value of $674,400.00.
• On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The stock was sold at an average price of $21.33, for a total value of $4,866,482.16.
• On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.03, for a total value of $2,003,000.00.
• On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The shares were sold at an average price of $18.74, for a total value of $5,285,991.80.

Alignment Healthcare Stock Up 2.3%

Shares of NASDAQ ALHC traded up $0.41 during midday trading on Tuesday, hitting $17.92. 2,947,535 shares of the company’s stock were exchanged, compared to its average volume of 2,922,050. The firm’s fifty day simple moving average is $20.69 and its 200-day simple moving average is $18.78. The company has a market cap of $3.66 billion, a PE ratio of -1,790.21, a P/E/G ratio of 2.49 and a beta of 1.19. Alignment Healthcare, Inc. has a twelve month low of $11.63 and a twelve month high of $23.87. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.71 and a quick ratio of 1.71.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.10. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1 billion. During the same period in the prior year, the firm posted ($0.16) earnings per share. The firm’s revenue was up 44.4% on a year-over-year basis. Research analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ALHC. TD Cowen lifted their target price on Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a research report on Friday, January 16th. Piper Sandler upped their target price on Alignment Healthcare from $20.00 to $30.00 and gave the company an “overweight” rating in a research report on Tuesday, January 6th. Robert W. Baird set a $28.00 price target on Alignment Healthcare in a research note on Friday, January 30th. JPMorgan Chase & Co. lifted their price target on Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $24.56.

Institutional Trading of Alignment Healthcare

Hedge funds have recently added to or reduced their stakes in the stock. Summit Securities Group LLC purchased a new position in shares of Alignment Healthcare in the 4th quarter valued at approximately $26,000. Parallel Advisors LLC raised its stake in shares of Alignment Healthcare by 87.7% during the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after purchasing an additional 773 shares during the last quarter. Larson Financial Group LLC acquired a new stake in shares of Alignment Healthcare during the third quarter worth $33,000. First Horizon Corp purchased a new position in Alignment Healthcare in the 4th quarter valued at $39,000. Finally, SBI Securities Co. Ltd. grew its position in Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after buying an additional 2,970 shares during the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.